Human Xenobiotic Nuclear Receptor PXR AugmentsMycobacterium tuberculosisSurvival
Author(s) -
Ella Bhagyaraj,
Ravikanth Nanduri,
Ankita Saini,
Hedwin Kitdorlang Dkhar,
Nancy Ahuja,
Vemika Chandra,
Sahil Mahajan,
Rashi Kalra,
Drishti Tiwari,
Charu Sharma,
Ashok K. Janmeja,
Pawan Gupta
Publication year - 2016
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1600203
Subject(s) - pregnane x receptor , mycobacterium tuberculosis , tuberculosis , nuclear receptor , inflammation , biology , receptor , in vivo , immunology , microbiology and biotechnology , cancer research , medicine , transcription factor , biochemistry , pathology , gene
Mycobacterium tuberculosis can evade host defense processes, thereby ensuring its survival and pathogenesis. In this study, we investigated the role of nuclear receptor, pregnane X receptor (PXR), in M. tuberculosis infection in human monocyte-derived macrophages. In this study, we demonstrate that PXR augments M. tuberculosis survival inside the host macrophages by promoting the foamy macrophage formation and abrogating phagolysosomal fusion, inflammation, and apoptosis. Additionally, M. tuberculosis cell wall lipids, particularly mycolic acids, crosstalk with human PXR (hPXR) by interacting with its promiscuous ligand binding domain. To confirm our in vitro findings and to avoid the reported species barrier in PXR function, we adopted an in vivo mouse model expressing hPXR, wherein expression of hPXR in mice promotes M. tuberculosis survival. Therefore, pharmacological intervention and designing antagonists to hPXR may prove to be a promising adjunct therapy for tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom